Results 151 to 160 of about 30,985 (250)

Mitochondrial CLPP in Health and Disease: Mechanisms, Therapeutic Duality and Emerging Opportunities

Journal of Inherited Metabolic Disease, Volume 49, Issue 5, September 2026.
The graphical abstract illustrates the context‐dependent therapeutic modulation of CLPP. Pharmacological CLPP activation has reached clinical application in cancer (black arrow), whereas reduced CLPP activity has shown beneficial effects experimentally in models of primary mitochondrial disease and metabolic syndrome, as well as cancer (grey arrows ...
Lea Isermann, Aleksandra Trifunovic
wiley   +1 more source

Mevalonate in blood and muscle: Response to atorvastatin treatment and the relationship to statin intolerance in patients with coronary heart disease

Clinical and Translational Science
Statin‐associated muscle symptoms are frequently reported and often lead to discontinuation of statin therapy with an increased risk of cardiovascular events.
Trine Lauritzen, John Munkhaugen, Stein Bergan, Elise Sverre, Kari Peersen, Sofia Lindahl, Einar Husebye, Nils Tore Vethe   +7 more
doaj   +1 more source

Ferroptosis: Newly Emerged Regulator for Human Disease

MedComm, Volume 7, Issue 9, September 2026.
Ferroptosis is a key regulated cell death pathway closely involved in cancers, neurodegenerative disorders, acute organ injuries, and cardiovascular and chronic metabolic diseases, representing a promising therapeutic target for diverse human illnesses.
Dandan Xiao, Lin Ye, Tianqi Jiang, Mengyuan Liu, Yuxia Zhou   +4 more
wiley   +1 more source

Metabolism in Tumor: Mechanisms and Therapeutic Perspectives

MedComm, Volume 7, Issue 9, September 2026.
Tumor metabolic reprogramming converges on three hubs—the SREBP1/2–FASN–SCD1 lipogenic axis, the HIF‐1α–GLUT1–LDHA glycolytic axis, and the LDLR–SCARB1–LXR cholesterol system—which integrate transcriptional, epigenetic (histone lactylation, m6A), and microenvironmental inputs to generate metabolic plasticity, immune evasion, and therapy resistance ...
Jia‐Chen Cheng, Yi‐Xuan Hu, Xiang‐Chun Huang, Shan Jiang, Jie‐Lin Wang, Yang Zhao, Shuo Chen   +6 more
wiley   +1 more source

Protein Posttranslational Modifications in Immunity: Molecular Mechanisms and Therapeutic Targets

MedComm, Volume 7, Issue 9, September 2026.
Protein posttranslational modifications, including phosphorylation, ubiquitination, SUMOylation, acetylation, methylation, glycosylation, and other new types, dynamically regulate antigen presentation and recognition, immune signal transduction, antibody production and class switching, immune contraction, immune memory establishment, as well as immune ...
Yuxing Yao, Jinxiu Qian, Qiqiong Liu, Wanting Ye, Ying Xing, Xiuyun Bai, Rongjun Deng, Jue Yang, Cheng Lu, Cheng Xiao, Yuanyan Liu   +10 more
wiley   +1 more source

BIOTECHNOLOGICAL APPLICATIONS OF MEVALONATE TRANSPORT IN SACCHAROMYCES CEREVISIAE

The mevalonate pathway is an evolutionarily conserved metabolic pathway which plays a crucial role in producing essential metabolites that regulate membrane fluidity, electron transport, and post-translational modifications of proteins.
Wegner, Scott A
core  

Mevalonate Kinase Deficiency

, 2019
Mevalonate kinase deficiency (MKD) is a rare autoinflammatory disease caused by loss of function mutations in both alleles of MVK, the gene encoding the enzyme mevalonate kinase. Deficiency of this enzyme results in impaired isoprenoid biosynthesis.
Frenkel, Joost, Simon, Anna, Child Health, Arts-assistenten Kinderen   +3 more
core  

Oxysterols in Cancer: From Biosynthesis and Pathophysiology to Targeted Therapeutics

MedComm – Oncology, Volume 5, Issue 3, September 2026.
Mechanisms by which oxysterol targeting may enhance immunotherapy efficacy. This figure illustrates potential metabolic interventions that may improve antitumor immunity by modulating oxysterol related pathways. CH25H modulation may reduce 25‐HC accumulation, promote the conversion of cold tumors into hot tumors, and increase T cell infiltration and PD‐
Haili Shang, Yongsheng Li
wiley   +1 more source

Rhythmic activity of utilization of mevalonate for biogenesis of cholesterol

, 1977
The utilization of mevalonate for biogenesis of cholesterol shows rhythmic activity with a peak at midnight and the step responsible is likely to be between mevalonate and isopentenyl ...
Ramasarma, T, Bhat, C Shama
core  

The HMG‐CoA Reductase Inhibitor Fluvastatin Promotes Th2‐Skewed Immune Responses by Modulating Dendritic Cell Differentiation

Genes to Cells, Volume 31, Issue 5, September 2026.
Fluvastatin promotes Th2‐skewed immune responses through direct effects on CD4+ T cells and, importantly, by altering dendritic cells (DCs) during differentiation. Continuous exposure at a near‐physiological concentration modifies DC phenotype and enhances their subsequent Th2‐polarizing capacity.
Satoshi Ishikawa, Haruka Mizuno, Kanon Murase, Kazuki Sasano, Isamu Ogawa, Yuka Itoh, Saotomo Itoh, Shigeaki Hida   +7 more
wiley   +1 more source